Dr. Lee Zehngebot Speaks with Fox 35 News about the Breakthrough Clinical Trial for Melanoma Patients
Click here to see Dr. Lee Zehngebot, Director of Clinical Trials at Florida Hospital Cancer Institute, talk about the melanoma shrinking drug Zelboraf that was just approved through a clinical trial at Florida Hospital Cancer Institute. This drug has a 50-70% response rate for shrinking existing melanomas. This drug is for patients whose melanoma has spread beyond the skin. Florida Hospital Cancer Institute continues our exciting work in clinical trials. To learn more, please visit Clinical Trials.










